Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Nivolumab-Induced Fulminant Immune-Related Colitis Despite Infliximab in a Patient With NSCLC.

Callens R, Tamsin A, van Zandweghe L.

J Thorac Oncol. 2019 Mar;14(3):e49-e50. doi: 10.1016/j.jtho.2018.11.014. No abstract available.

PMID:
30782382
2.

Does nivolumab for progressed metastatic lung cancer fulfill its promises? An efficacy and safety analysis in 20 general hospitals.

Tournoy KG, Thomeer M, Germonpré P, Derijcke S, De Pauw R, Galdermans D, Govaert K, Govaerts E, Schildermans R, Declercq I, De Brucker N, Pat K, Van Herreweghe R, Van Zandweghe L, Vanmaele L, Van Damme V, Marien H, De Craene S, Fabry I, Alexander P, Vercauter P, Demedts I.

Lung Cancer. 2018 Jan;115:49-55. doi: 10.1016/j.lungcan.2017.11.008. Epub 2017 Nov 16.

PMID:
29290261
3.

EBUS-TBNA in the workup of a mediastinal mass.

Yserbyt J, Van Zandweghe L, De Wever W, Dooms C.

J Bronchology Interv Pulmonol. 2012 Apr;19(2):162-4. doi: 10.1097/LBR.0b013e318250341e.

PMID:
23207365

Supplemental Content

Loading ...
Support Center